Iron overload in an African American woman with SS hemoglobinopathy and a promoter mutation in the X-linked erythroid-specific 5-aminolevulinate synthase (ALAS2) gene.

被引：0
|
作者：
Barton, JC
Lee, PL
Bertoli, LF
Beutler, E
机构：
[1] So Iron Disorders Ctr, Brookwood Med Ctr, Birmingham, AL USA
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3683.3683
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3683
引用
收藏
页码：6B / 7B
页数：2
相关论文
共 26 条
  • [1] Iron overload in an African American woman with SS hemoglobinopathy and a promoter mutation in the X-linked erythroid-specific 5-aminolevulinate synthase (ALAS2) gene
    Barton, JC
    Lee, PL
    Bertoli, LF
    Beutler, E
    BLOOD CELLS MOLECULES AND DISEASES, 2005, 34 (03) : 226 - 228
  • [2] A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia
    Bekri, S
    May, A
    Cotter, PD
    Al-Sabah, AI
    Guo, XJ
    Masters, GS
    Bishop, DF
    BLOOD, 2003, 102 (02) : 698 - 704
  • [3] X-LINKED SIDEROBLASTIC ANEMIA - IDENTIFICATION OF THE MUTATION IN THE ERYTHROID-SPECIFIC DELTA-AMINOLEVULINATE SYNTHASE GENE (ALAS2) IN THE ORIGINAL FAMILY DESCRIBED BY COOLEY
    COTTER, PD
    RUCKNAGEL, DL
    BISHOP, DF
    BLOOD, 1994, 84 (11) : 3915 - 3924
  • [4] Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia:: Increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis
    Cotter, PD
    May, A
    Li, LP
    Al-Sabah, AI
    Fitzsimons, EJ
    Cazzola, M
    Bishop, DF
    BLOOD, 1999, 93 (05) : 1757 - 1769
  • [5] X-LINKED SIDEROBLASTIC ANEMIA: A PROMOTER MUTATION IN THE ALAS2 GENE
    Pereira, J.
    Pereira, A.
    Maia, T.
    Relvas, L.
    Almeida, H.
    Bento, C.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2013, 98 : 419 - 420
  • [6] Aberrant iron accumulation and oxidized status of erythroid-specific δ-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts
    Harigae, H
    Nakajima, O
    Suwabe, N
    Yokoyama, H
    Furuyama, K
    Sasaki, T
    Kaku, M
    Yamamoto, M
    Sassa, S
    BLOOD, 2003, 101 (03) : 1188 - 1193
  • [7] Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene
    Furuyama, K
    Fujita, H
    Nagai, T
    Yomogida, K
    Munakata, H
    Kondo, M
    Kimura, A
    Kuramoto, A
    Hayashi, N
    Yamamoto, M
    BLOOD, 1997, 90 (02) : 822 - 830
  • [8] Molecular Expression and Characterization of Erythroid-Specific 5-Aminolevulinate Synthase Gain-of-Function Mutations Causing X-Linked Protoporphyria
    David F. Bishop
    Vassili Tchaikovskii
    Irina Nazarenko
    Robert J. Desnick
    Molecular Medicine, 2013, 19 : 18 - 25
  • [9] Molecular Expression and Characterization of Erythroid-Specific 5-Aminolevulinate Synthase Gain-of-Function Mutations Causing X-Linked Protoporphyria
    Bishop, David F.
    Tchaikovskii, Vassili
    Nazarenko, Irina
    Desnick, Robert J.
    MOLECULAR MEDICINE, 2013, 19 : 18 - 25
  • [10] Aberrant iron accumulation and peroxidized status of erythroid-specific δ-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts.
    Harigae, H
    Nakajima, O
    Furuyama, K
    Yokoyama, H
    Ishizawa, K
    Miyamura, K
    Kameoka, J
    Sasaki, T
    Kaku, M
    Yamamoto, M
    Sassa, S
    BLOOD, 2002, 100 (11) : 6A - 6A
123